Novus Therapeutics(NVUS)2020-04-01 04:10
$Novus Therapeutics(NVUS)$ DEF 14A Other definitive proxy statements Accession Number: 0001564590-20-014525 Act: 34 Size: 1 MB 网页链接查看全文
Novus Therapeutics(NVUS)2020-03-17 18:10
$Novus Therapeutics(NVUS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-011260 Act: 34 Size: 7 MB 网页链接查看全文
Novus Therapeutics(NVUS)2020-04-01 04:10
$Novus Therapeutics(NVUS)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-014526 Act: 34 Size: 208 KB 网页链接查看全文
Novus Therapeutics(NVUS)2020-03-16 18:25
$Novus Therapeutics(NVUS)$ PRE 14A Other preliminary proxy statements Accession Number: 0001564590-20-010887 Act: 34 Size: 1 MB 网页链接查看全文
Novus Therapeutics(NVUS)2020-04-06 18:10
$Novus Therapeutics(NVUS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000680 Act: 33 Size: 1 KB 网页链接查看全文
Novus Therapeutics(NVUS)2020-03-21 04:40
$Novus Therapeutics(NVUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-009124 Size: 5 KB 网页链接查看全文
Novus Therapeutics(NVUS)2020-02-26 06:10
$Novus Therapeutics(NVUS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-20-000143 Act: 34 Size: 79 KB 网页链接查看全文
$Novus Therapeutics(NVUS)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-06-07 AccNo: 0001193125-19-168171 Size: 252 KB 网页链接
$Novus Therapeutics(NVUS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-06-05 AccNo: 0000919574-19-003970 Size: 118 KB 网页链接
$Novus Therapeutics(NVUS)$ DEF 14A - Other definitive proxy statements Filed: 2019-05-15 AccNo: 0001564590-19-019430 Size: 982 KB 网页链接
$Novus Therapeutics(NVUS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-05-15 AccNo: 0001564590-19-019437 Size: 176 KB 网页链接
$Novus Therapeutics(NVUS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-14 AccNo: 0001564590-19-019134 Size: 3 MB 网页链接
$Novus Therapeutics(NVUS)$ 8-K - Current report Filed: 2019-05-14 AccNo: 0001564590-19-019162 Size: 255 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Novus Therapeutics(NVUS)$ D - Notice of Exempt Offering of Securities Filed: 2019-05-10 AccNo: 0001209191-19-028847 Size: 13 KB 网页链接
$Novus Therapeutics(NVUS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-05-10 AccNo: 0000921895-19-001354 Size: 229 KB 网页链接
$Novus Therapeutics(NVUS)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-05-06 AccNo: 0000947871-19-000328 Size: 125 KB 网页链接
$Novus Therapeutics(NVUS)$ 内部交易: 2019-05-02,Director,Chimovits Erez ,买入,646204普通股, $3.10